Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2010
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239676 Stable Aerosolizable Suspensions of Proteins in Ethanol
09/23/2010US20100239671 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239574 High potency recombinant antibodies and method for producing them
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof
09/23/2010US20100239507 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles
09/23/2010DE102009014166A1 Product, useful to prevent and treat e.g. acute respiratory diseases such as bronchitis, cough, allergy symptoms and asthma attacks and damages caused by inhalation of atmospheric air pollutants, comprises cobalamin
09/23/2010DE102009014165A1 Product, useful e.g. to treat and prevent disorders or diseases of lungs, cardiovascular and neuronal system caused by inhalation of tobacco smoke and respiratory diseases e.g. asthma, bronchitis and chronic cough, comprises cobalamin
09/23/2010CA2755697A1 Amide derivative
09/22/2010EP2230307A1 Neutrokine alpha
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
09/22/2010EP2229377A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
09/22/2010EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010CN201586232U Vitamin C fructus forsythiae soft capsule
09/22/2010CN1947722B Blood sugar regulator used during user having meals and its preparation method
09/22/2010CN1943729B A Chinese traditional medicinal composition for treatment of exopathic febrile disease and its preparation method
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN1658872B Antiallergic
09/22/2010CN101842361A Pyrazinone derivatives and their use in the treatment of lung diseases
09/22/2010CN101842355A Substituted n-aryl pyridinones as fibrotic inhibitors
09/22/2010CN101842090A Topical composition for treating pain
09/22/2010CN101838587A Method for extracting natural Chinese herbal medicinal flavor component and application of extractive thereof
09/22/2010CN101838327A Human IL-15 subtype protein and preparation method and application thereof
09/22/2010CN101838277A Cefotetan disodium hydrate and preparation method and application thereof
09/22/2010CN101837132A HN1 strain gB gene and avian 1L-18 gene combined nucleic acid vaccine of avian infectious laryngotracheitis virus and preparation method thereof
09/22/2010CN101837089A Chinese medicinal herb extract for clearing away heat and toxic material and method for preparing preparation thereof
09/22/2010CN101837073A Compound medicinal composition for treating avian infectious bronchitis and preparation method thereof
09/22/2010CN101837050A Medicament for curing lung cancer and preparation method thereof
09/22/2010CN101837047A Method for preparing concentrated Yinhuang oral liquid
09/22/2010CN101837028A Selaginella uncinata extract dripping pill and preparation method thereof
09/22/2010CN101836965A Orally disintegrating tablet containing fexofenadine or salts of fexofenadine, and preparation method thereof
09/22/2010CN101836953A Ambroxol hydrochloride composition injection
09/22/2010CN101836952A Ambroxol injection and preparation method thereof
09/22/2010CN101836951A Ambroxol-hydrochloride-containing oral solution and preparation method thereof
09/22/2010CN101347437B Medicament composition for treating respiratory disease
09/22/2010CN101347436B Uses of methylprednisolone and derivatives thereof in preparing medicament for treating allergic rhinitis
09/22/2010CN101306157B Traditional Chinese medicine for treating tonsillitis
09/22/2010CN101239160B Chinese medicine perfume composition and its sachet agent and fumigant
09/22/2010CN101224273B Preparing method of Jiaozhi soft capsule
09/22/2010CN101218951B Internal mixing loquat leaf and Sichuan fritillary bulb bonbon
09/21/2010US7799922 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010CA2530492C Portable electrotherapy device for knee joint maladies
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2433280C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/21/2010CA2365890C Method for delivering benzindene prostaglandins by inhalation
09/16/2010WO2010104961A1 Treatment methods for autoimmune disorders
09/16/2010WO2010104959A1 Treatment and diagnostic methods for hypersensitive disorders
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103959A1 Ameliorating agent for chronic obstructive pulmonary disease
09/16/2010WO2010103297A2 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103279A1 Bis aromatic compounds for use as lct4 synthase inhibitors
09/16/2010WO2010103278A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103274A1 Antibody molecules having binding specificity for human il-13
09/16/2010WO2010102968A1 Indole derivatives as ikk2 inhibitors
09/16/2010WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
09/16/2010WO2010102831A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy) hexyl]amino}-l- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one.
09/16/2010WO2010057118A3 Heterocyclic antagonists of prostaglandin d2 receptors
09/16/2010WO2010054221A3 Treatment of chronic inflammatory respiratory disorders
09/16/2010WO2010048526A3 Modulators of cystic fibrosis transmembrane conductance regulator
09/16/2010WO2010005770A8 Electrostatically charged nasal application multipurpose products and method
09/16/2010US20100234473 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines
09/16/2010US20100234449 Immunostimulatory Method
09/16/2010US20100234423 Triazolothiadiazole inhibitor of c-met protein kinase
09/16/2010US20100234411 New Combination for the Treatment of Respiratory Diseases
09/16/2010US20100234396 Tetrhydropyridoindole Derivatives
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234386 Quinoxaline derivatives as pi3 kinase inhibitors
09/16/2010US20100234384 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
09/16/2010US20100234382 Composition comprising a pde4 inhibitor and a pde5 inhibitor
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234368 Condensed ring compound and use thereof
09/16/2010US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234346 Novel pyrimidine derivatives
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 878